335 related articles for article (PubMed ID: 32994348)
1. Reply to Patella et al. and Lindestam Arlehamn et al.: Complex pandemic dynamics and effect of bacillus Calmette-Guérin (BCG) vaccination on COVID-19 prevalence and mortality.
Barillas-Mury C; Escobar LE; Molina-Cruz A
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25207-25208. PubMed ID: 32994348
[No Abstract] [Full Text] [Related]
2. The bacillus Calmette-Guérin vaccination allows the innate immune system to provide protection from severe COVID-19 infection.
Patella V; Delfino G; Bruzzese D; Giuliano A; Sanduzzi A
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25205-25206. PubMed ID: 32994349
[No Abstract] [Full Text] [Related]
3. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
4. Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?
O'Connor E; Teh J; Kamat AM; Lawrentschuk N
Future Oncol; 2020 Jul; 16(19):1323-1325. PubMed ID: 32406253
[No Abstract] [Full Text] [Related]
5. Impact of Routine Infant BCG Vaccination on COVID-19.
Kinoshita M; Tanaka M
J Infect; 2020 Oct; 81(4):625-633. PubMed ID: 32795481
[TBL] [Abstract][Full Text] [Related]
6. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and Bacillus Calmette-Guérin: What is the Link?
Hegarty PK; Sfakianos JP; Giannarini G; DiNardo AR; Kamat AM
Eur Urol Oncol; 2020 Jun; 3(3):259-261. PubMed ID: 32327396
[TBL] [Abstract][Full Text] [Related]
8. [Progress in possible effects of BCG vaccine on the prevention of SARS-CoV-2 infection: An update].
Huang W; Liu T; Feng G; Wang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1044-1048. PubMed ID: 33210600
[TBL] [Abstract][Full Text] [Related]
9. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
Tomita Y; Sato R; Ikeda T; Sakagami T
Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070
[TBL] [Abstract][Full Text] [Related]
10. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
11. Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).
Riccò M; Gualerzi G; Ranzieri S; Bragazzi NL
Acta Biomed; 2020 May; 91(2):207-213. PubMed ID: 32420947
[TBL] [Abstract][Full Text] [Related]
12. BCG Vaccination Policy and Protection Against COVID-19: Correspondence.
Mohapatra PR; Mishra B
Indian J Pediatr; 2020 Sep; 87(9):772-773. PubMed ID: 32779000
[No Abstract] [Full Text] [Related]
13. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
[TBL] [Abstract][Full Text] [Related]
14. Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19.
Kumar A; Misra S; Verma V; Vishwakarma RK; Kamal VK; Nath M; Prakash K; Upadhyay AD; Sahu JK
PLoS One; 2020; 15(10):e0240710. PubMed ID: 33091086
[TBL] [Abstract][Full Text] [Related]
15. Factors determining COVID-19 pneumonia severity in a country with routine BCG vaccination.
Aksu K; Naziroğlu T; Özkan P
Clin Exp Immunol; 2020 Nov; 202(2):220-225. PubMed ID: 32813879
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccination clinical trials should consider multiple doses of BCG.
Ayoub BM
Pharmazie; 2020 Apr; 75(4):159. PubMed ID: 32295694
[No Abstract] [Full Text] [Related]
17. [DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)].
Otto-Knapp R; Häcker B; Breuer C; Diel R; Kaufmann SHE; Korr G; Pfeiffer M; Schaberg T; Schönfeld N; Witte P; Bauer T
Pneumologie; 2020 Jul; 74(7):412-416. PubMed ID: 32674189
[No Abstract] [Full Text] [Related]
18. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
[TBL] [Abstract][Full Text] [Related]
19. Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed.
Schaaf HS; du Preez K; Kruger M; Solomons R; Taljaard JJ; Rabie H; Seddon JA; Cotton MF; Tebruegge M; Curtis N; Hesseling AC
Int J Tuberc Lung Dis; 2020 Jul; 24(7):732-734. PubMed ID: 32718410
[No Abstract] [Full Text] [Related]
20. Considering BCG vaccination to reduce the impact of COVID-19.
Curtis N; Sparrow A; Ghebreyesus TA; Netea MG
Lancet; 2020 May; 395(10236):1545-1546. PubMed ID: 32359402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
